G01N 2440/28
Pegylation
Official title: PEGylation
G01N2440/28 (Pegylation) appears on 3 US grants and 7 published applications in this corpus.
Search patents in G01N- Granted patents
- 3
- Published applications
- 7
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 14 Mar 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Sensitive method to analyse free PEG-maleimide14 Mar 2017US 9,594,025 B2Bristol-Myers Squibb Company
- Preparation of anti-PEG antibody expressing cell and application thereof3 May 2016US 9,329,180 B2Kaohsiung Medical University
- Sensitive method to analyse free PEG-maleimide31 Mar 2015US 8,993,350 B2Bristol-Myers Squibb Company
- An improved method for separating and detecting of free or residual polyethylene glycol in pegylated protein mixture31 Jul 2025US 2025/0244334 A1
- Anti-peg antibody binding material and method for detecting anti-peg antibody5 Jun 2025US 2025/0180546 A1DKS Co. Ltd.
- Plasmonic nanoparticle platform for analyte detection29 Aug 2024US 2024/0288374 A1
- Multimers for reducing the interference of drugs that bind cd47 in serological assays23 Jun 2022US 2022/0196651 A1ALX Oncology Inc.
- Sensitive method to analyse free peg-maleimide9 Jul 2015US 2015/0192524 A1Bristol-Myers Squibb Company
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.